Loading clinical trials...
Loading clinical trials...
Evaluation of the Impact of a Nurse-led Telephone Follow-up on Treatment Compliance of Patients Treated From a Locally Advanced or Metastatic Non-small-cell Lung Cancer (NSCLC) With Activating Epidermal Growth Factor Receptor (EGFR) Mutation(s).The PARTAGE Study.
Conditions
Locations
36
France
CLI Dr Calabet, Oncolgie, Agen
Agen, France
HOP Centre Hospitalier Pays d'Aix, Pneumo, Aix en Provence
Aix-en-Provence, France
CLI Polyclinique du Parc Rambot, Pneumo, Aix en Provence
Aix-en-Provence, France
HOP Centre Marie Curie, Onco, Arras
Arras, France
HOP Centre Hospitalier de Béziers, Pneumo, Béziers
Béziers, France
CLI Bordeaux Nord Aquitaine
Bordeaux, France
Start Date
November 19, 2015
Primary Completion Date
February 27, 2017
Completion Date
February 27, 2017
Last Updated
March 1, 2019
NCT04165798
NCT06667908
NCT06875310
NCT07046923
NCT07222566
NCT06667076
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions